Lipella Pharmaceuticals Inc (LIPO) Market Value

The Lipella Pharmaceuticals (LIPO) price chart on the GURU.Markets platform illustrates market metrics where the capitalization stands at 0.00. The company's progress relies on the development of targeted bladder drug delivery systems to combat hemorrhagic cystitis. Management is betting on urological innovations with low side-effect profiles. Patent protection and the complexity of biochemical formulas create significant barriers to entry for new players.

LIPO Lipella Pharmaceuticals, Inc.: Market Value in the range 04/28/2023 - 07/19/2025

Comprehensive metric breakdowns and analytics for Lipella Pharma (LIPO)

- current price and projected stock value:

Stock Price Lipella Pharmaceuticals, Inc.|LIPO - Analyst Median Target

- market capitalization details:

Market Value Lipella Pharma|LIPO - Full Business Value

- book value of equity indicators:

Net Assets per Single Share Lipella Pharmaceuticals|LIPO - Total Stockholders' Equity|Market Value to Book Value Ratio lipella.com|LIPO - Total Asset Value of Company

- debt burden and liquidity indicators:

Total Debt to Capital Lipella Pharmaceuticals|LIPO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Lipella Pharmaceuticals|LIPO - Company Aggregate Debts|Debt to Book Capitalization Ratio Lipella Pharma|LIPO - Company Long-Term Loans and Borrowings|Company Short-Term Debt Lipella Pharmaceuticals|Quick Ratio lipella.com

- business earnings and investment ratios data:

LIPO - Net Profit|Future Profit Lipella Pharmaceuticals|LIPO - Company Value to Net Income|Future Price to Earnings Lipella|LIPO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Lipella Pharma|LIPO - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Lipella Pharmaceuticals|LIPO - Earnings per share for the trailing year|Quarterly EPS earnings growth lipella.com|LIPO - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Lipella Pharmaceuticals

Fundamental company analysis:LIPO (Lipella Pharmaceuticals, Inc.)

Market capitalization represents the aggregate value of all shares, reflecting the market's current valuation of the business's future cash flow. This indicator measures the total asset value through the lens of investor expectations. The market capitalization dynamics of Lipella Pharmaceuticals (LIPO) demonstrate the market's reaction to the development of the targeted drug delivery ecosystem for urology. Growth in this metric confirms the recognized value of local tissue therapy. This positive trend enhances the asset's investment attractiveness.

Key competitors